Raiffeisen Bank International AG Sells 20,000 Shares of Acadia Healthcare Company, Inc. $ACHC

Raiffeisen Bank International AG trimmed its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 18.2% during the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 90,000 shares of the company’s stock after selling 20,000 shares during the quarter. Raiffeisen Bank International AG’s holdings in Acadia Healthcare were worth $2,492,000 as of its most recent SEC filing.

Other hedge funds also recently bought and sold shares of the company. Braidwell LP boosted its position in Acadia Healthcare by 76.7% during the 2nd quarter. Braidwell LP now owns 1,141,477 shares of the company’s stock valued at $33,708,000 after acquiring an additional 495,577 shares in the last quarter. Hsbc Holdings PLC bought a new position in shares of Acadia Healthcare in the 2nd quarter worth $1,045,000. Empowered Funds LLC purchased a new stake in shares of Acadia Healthcare during the 2nd quarter worth $206,000. United Capital Financial Advisors LLC bought a new stake in Acadia Healthcare during the second quarter valued at about $425,000. Finally, Jefferies Financial Group Inc. purchased a new position in Acadia Healthcare in the second quarter valued at about $106,458,000.

Acadia Healthcare Price Performance

Shares of ACHC opened at $28.13 on Friday. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.57 and a quick ratio of 1.57. The company’s fifty day moving average price is $30.70 and its 200-day moving average price is $26.51. Acadia Healthcare Company, Inc. has a 1-year low of $11.43 and a 1-year high of $35.83. The firm has a market capitalization of $2.62 billion, a PE ratio of -2.26, a price-to-earnings-growth ratio of 9.14 and a beta of 0.62.

Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The company had revenue of $865.84 million during the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm’s quarterly revenue was down .4% on a year-over-year basis. During the same quarter last year, the business posted $0.83 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, equities research analysts predict that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Analyst Upgrades and Downgrades

Several research firms have commented on ACHC. Jefferies Financial Group raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and increased their price target for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. KeyCorp lifted their price objective on shares of Acadia Healthcare from $30.00 to $40.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 14th. Cantor Fitzgerald reissued a “neutral” rating on shares of Acadia Healthcare in a research report on Wednesday, July 29th. TD Cowen raised their target price on shares of Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Friday, June 12th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, Acadia Healthcare currently has a consensus rating of “Hold” and an average price target of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.